AR024364A1 - Una composicion cosmetica para el adelgazamiento a base l-arginina, de un analogo de l-arginina, o de uno de sus derivados, que se administra por viatopica - Google Patents

Una composicion cosmetica para el adelgazamiento a base l-arginina, de un analogo de l-arginina, o de uno de sus derivados, que se administra por viatopica

Info

Publication number
AR024364A1
AR024364A1 ARP000102951A ARP000102951A AR024364A1 AR 024364 A1 AR024364 A1 AR 024364A1 AR P000102951 A ARP000102951 A AR P000102951A AR P000102951 A ARP000102951 A AR P000102951A AR 024364 A1 AR024364 A1 AR 024364A1
Authority
AR
Argentina
Prior art keywords
arginine
derivatives
viatopica
slimming
administered
Prior art date
Application number
ARP000102951A
Other languages
English (en)
Original Assignee
Exsymol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exsymol Sa filed Critical Exsymol Sa
Publication of AR024364A1 publication Critical patent/AR024364A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta composicion se caracteriza en lo que incluye, en asociacion con todo excipiente cosmético apropiado, al menos un compuesto que es la L-arginina, unanálogo de la L-arginina o uno de sus derivados, o cualquiera otra de sus sales, el dichocompuest o tiene la formula general (1) en la cual: R1 representa unátomo de hidrogeno, un grupo hidroxilo, un radical acilo, aciloxi, o un aminoácido substituido o no en su funcion alfa-aminada libre, vinculado por un enlacepeptídico; R2 representaun grupo hidroxilo, un radical amino, alquilamino o alcoxi, un grupo sililoxi, o un aminoácido sustituído o no en su funcion alfa-carboxílica libre, vinculado por un enlace peptídico y n es igual a 3 o 4.
ARP000102951A 1999-06-16 2000-06-15 Una composicion cosmetica para el adelgazamiento a base l-arginina, de un analogo de l-arginina, o de uno de sus derivados, que se administra por viatopica AR024364A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907631A FR2794974B1 (fr) 1999-06-16 1999-06-16 Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique

Publications (1)

Publication Number Publication Date
AR024364A1 true AR024364A1 (es) 2002-10-02

Family

ID=9546881

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102951A AR024364A1 (es) 1999-06-16 2000-06-15 Una composicion cosmetica para el adelgazamiento a base l-arginina, de un analogo de l-arginina, o de uno de sus derivados, que se administra por viatopica

Country Status (8)

Country Link
US (1) US6716436B1 (es)
EP (1) EP1060739B1 (es)
JP (1) JP4833394B2 (es)
CN (1) CN1159003C (es)
AR (1) AR024364A1 (es)
BR (1) BR0002763B1 (es)
ES (1) ES2416280T3 (es)
FR (1) FR2794974B1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
JP2002193782A (ja) * 2000-12-22 2002-07-10 Shiyuu Uemura Keshohin:Kk 皮膚化粧料
MC200058A1 (fr) 2002-04-05 2003-01-30 A M Exsymol S Analogues du dipeptide citrullinylarginine et leurs utilisations dermatologiques comme agents de soin et de traitement
FR2851460B1 (fr) * 2003-02-21 2007-05-11 Seppic Sa Utilisation de n-lauroyl aminoacides comme actif cosmetique et pharmaceutique amincissant
FR2851461B1 (fr) * 2003-02-21 2007-04-20 Seppic Sa Utilisation de n-octanoyl aminoacides comme actif cosmetique et pharmaceutique amincissant
WO2005081964A2 (en) * 2004-02-23 2005-09-09 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
WO2005102307A2 (en) 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
HUP0401422A2 (en) 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
FR2876004B1 (fr) * 2004-10-01 2007-04-06 Exsymol Sa Monegasque Utilisation d'algues rouges soumises a des conditions extremes de temperature et de luminosite
CA2587444C (en) * 2004-11-12 2013-09-10 Ucl Business Plc Guanidine derivatives as inhibitors of ddah
AU2008247488B2 (en) * 2007-05-04 2014-02-27 Marina Biotech, Inc. Amino acid lipids and uses thereof
FR2929118B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
JP4638963B2 (ja) * 2008-04-07 2011-02-23 敏 新川 痩身用化粧品組成物
FR2943253B1 (fr) 2009-03-20 2011-04-22 Oreal Composition contenant l'association de madecassoside, d'une arginine et de polysorbate
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
BRPI0925099A2 (pt) 2009-06-24 2018-10-16 Strategic Science & Tech Llc composição tópica contendo ibuprofeno
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
WO2012092523A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
FR3012958B1 (fr) * 2013-11-08 2016-01-01 Oreal Compositions cosmetiques comprenant de l'acide spiculisporique et au moins un tensioactif sulfate et/ou sulfonate
FR3023477B1 (fr) * 2014-07-10 2017-11-24 Oreal Utilisation cosmetique de l'acide spiculisporique comme actif deodorant
FR3117834B1 (fr) 2020-12-17 2023-11-10 Oreal Composition cosmétique biphase comprenant un acide aminé et deux acides spécifiques

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR958M (es) * 1961-01-18 1961-11-27
WO1980000252A1 (en) * 1978-07-18 1980-02-21 Kabi Ab Bradykinin-inhibiting tripeptide derivatives
DE3538749A1 (de) * 1985-10-31 1987-05-07 Merck Patent Gmbh Peptide
GB2199243A (en) * 1986-09-17 1988-07-06 Natural Vitality Ltd Pharmaceutical compositions comprising ornithine and arginine
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
FR2611496B1 (fr) * 1987-03-04 1992-07-03 Gueyne Jean Organo-silicies cosmetiques
LU87390A1 (fr) * 1988-11-17 1990-06-12 Oreal Utilisation du nicotinate d'alpha-tocopherol et/ou du nicotinate d'hexyle dans une composition cosmetique a action amincissante
FR2680686B1 (fr) * 1991-08-28 1993-11-05 Oreal Lotion tri-phases destinee a un usage corporel, pharmaceutique ou cosmetique.
JPH06199626A (ja) * 1992-12-28 1994-07-19 Yamakawa Boeki Kk 新規なオリゴペプチド含有美容製品調製用添加剤
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
FR2701948B1 (fr) * 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
JPH0733635A (ja) * 1993-07-21 1995-02-03 Kao Corp 皮膚外用剤
DE4341001A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
WO1996008265A1 (en) * 1994-09-12 1996-03-21 The Trustees Of The University Of Pennsylvania Corticotropin release inhibiting factor and methods of using same
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6211154B1 (en) * 1995-06-07 2001-04-03 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
JP4020989B2 (ja) * 1996-03-06 2007-12-12 株式会社ノエビア 血流促進剤及びこれを配合して成る皮膚外用剤
JPH10101546A (ja) * 1996-09-27 1998-04-21 Shiseido Co Ltd 皮膚外用剤
FR2758724B1 (fr) * 1997-01-24 1999-04-23 Javenech Composition topique a base de protamine pour le traitement de la cellulite et des surcharges ponderales
EP0969790A2 (de) * 1997-02-21 2000-01-12 Beiersdorf Aktiengesellschaft Zubereitungen für die behandlung von rosacea
FR2761074B1 (fr) * 1997-03-24 1999-05-28 Exsymol Sa Composes a base de silicium biologiquement actifs sous forme solide
ES2549329T3 (es) * 1997-09-17 2015-10-27 Strategic Science & Technologies, Llc Administración tópica de arginina para el tratamiento del dolor
US5874068A (en) * 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
JPH11269079A (ja) * 1998-03-17 1999-10-05 Shiseido Co Ltd 脂質分解促進用皮膚外用剤
JP3519269B2 (ja) * 1998-03-23 2004-04-12 株式会社資生堂 皮膚外用剤
TR200003384T2 (tr) * 1998-05-18 2001-03-21 Pharmacia & Upjohn Company Arginin türevleri kullanılarak oksazolidinon antibakteriyel maddelerin etkisinin arttırılması
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique

Also Published As

Publication number Publication date
JP4833394B2 (ja) 2011-12-07
CN1283447A (zh) 2001-02-14
ES2416280T3 (es) 2013-07-31
EP1060739B1 (fr) 2013-04-03
BR0002763A (pt) 2001-01-30
BR0002763B1 (pt) 2013-05-07
EP1060739A1 (fr) 2000-12-20
FR2794974B1 (fr) 2001-08-17
US6716436B1 (en) 2004-04-06
CN1159003C (zh) 2004-07-28
JP2001026514A (ja) 2001-01-30
FR2794974A1 (fr) 2000-12-22

Similar Documents

Publication Publication Date Title
AR024364A1 (es) Una composicion cosmetica para el adelgazamiento a base l-arginina, de un analogo de l-arginina, o de uno de sus derivados, que se administra por viatopica
AR024634A1 (es) Composicion farmaceutica estabilizada en forma liofilizada
CO5570660A2 (es) Indazolilpirrolotriazinas c-6 modificadas
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
CO5590895A2 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos
BRPI0619255B8 (pt) composto de peptídeo, composição farmacêutica, uso do composto e medicamento para imunoterapia de câncer
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
BR9808928A (pt) Complexo molecular e liberação controlada dealfa hidroxiácidos
BR0209434A (pt) Peptìdeos antimicrobianos e composições
BRPI0312882B8 (pt) derivados de pleuromutilina e composição farmacêutica
AR044650A1 (es) Derivados de tiofeno - pirimidinona y su uso en la terapia de enfermedades que requieren la inhibicion de la enzima 17b-hidroxiesteroide-dehidrogenasa.
CU23536A3 (es) Estabilizador de interleuquina 2
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
PE20000560A1 (es) Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica
NO20020725L (no) Celleadhesjonsinhibitorer
ATE304347T1 (de) Selbstbräunendes mittel enthaltend einen ester von einer n-acyl aminosäure
AR003136A1 (es) Peptidos de dolastatin, procedimiento para prepararlos, las composiciones farmaceuticas que los contienen y el uso de los mismos para preparar dichas composiciones farmaceuticas.
IL169257A0 (en) Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents
BR0007343A (pt) Aditivo anti-formação de mancha e composição depoliorganossiloxano curável a temperaturaambiente
BR0309558A (pt) Derivados de quinazolina e medicamentos
BR0302496A (pt) Composições farmacêuticas com atividade antibiótica
AR014714A1 (es) Sales de cetoacidos y derivados de aminas, y su utilizacion para la preparacion de medicamentos
DK278588A (da) Cycliske peptider med antikoagulerende virkning
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
AR035285A1 (es) Formulaciones en combinacion de derivados de1,4-benzotiepina-1,1-dioxido con otras sustancias activas, y su utilizacion.

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration